PAM
ALGS icon

Panagora Asset Management’s Aligos Therapeutics ALGS Stock Holding History

Panagora Asset Management’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$1K – 2756
2021
Q1 		$1K Hold
1
– – ﹤0.01% 2750
2020
Q4 		$1K Buy
+1
New +$487 ﹤0.01% 2689

Other funds holding ALGS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's ALGS Position: Q2 2021 in Review

Panagora Asset Management sold out of Aligos Therapeutics (ALGS) in Q2 2021, closing a stake of 1 share — an estimated $1K sold.

Panagora Asset Management first reported a position in ALGS in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 57 funds tracked by Wall St. Rank hold ALGS as of Q2 2021.

  • Panagora Asset Management reported no remaining Aligos Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1 Aligos Therapeutics share in Q2 2021, an estimated $1K.
  • Panagora Asset Management first reported a position in Aligos Therapeutics in Q4 2020 and held it in 2 quarters.
  • Panagora Asset Management's Aligos Therapeutics position peaked at $1K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.